E-LIB Suche - Ergebnisse für: Barnes, Gisoo

1

Tislelizumab versus Sorafenib in First-Line Treatment of Un..:

Finn, Richard S. ; Kudo, Masatoshi ; Barnes, Gisoo...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

2

Effects of tislelizumab on health‐related quality of life i..:

Yang, Yunpeng ; Pan, Jianji ; Chen, Nianyong...
Head & Neck. , 2024

Link: https://doi.org/10.1002/..

3

Second-line tislelizumab versus chemotherapy in Japanese pa..:

Hara, Hiroki ; Satoh, Taroh ; Kojima, Takashi...
Esophagus. 21 (2024) 2 - p. 102-110 , 2024

Link: https://doi.org/10.1007/..

4

The effects of tislelizumab treatment on the health‐related..:

Huang, Dingzhi ; Zhou, Caicun ; Barnes, Gisoo...
Cancer Medicine. 12 (2023) 16 - p. 17403-17412 , 2023

Link: https://doi.org/10.1002/..

5

P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WIT..:

Tedeschi, Alessandra ; Tam, Constantine ; Owen, Roger...
HemaSphere. 7 (2023) S3 - p. e27391ea , 2023

Link: https://doi.org/10.1097/..

6

Health-related quality of life outcomes associated with zan..:

Tam, Constantine S. ; Lamanna, Nicole ; O'Brien, Susan M....
Current Medical Research and Opinion. 39 (2023) 11 - p. 1497-1503 , 2023

Link: https://doi.org/10.1080/..

7

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRO..:

Eichhorst, Barbara ; Lamanna, Nicole ; O'brien, Susan...
HemaSphere. 7 (2023) S3 - p. e02428b9 , 2023

Link: https://doi.org/10.1097/..

8

Health-related quality-of-life in treatment-naive CLL/SLL p..:

Ghia, Paolo ; Barnes, Gisoo ; Yang, Keri...
Current Medical Research and Opinion. 39 (2023) 11 - p. 1505-1511 , 2023

Link: https://doi.org/10.1080/..

9

Tislelizumab in advanced/metastatic esophageal squamous cel..:

Kim, Sung-Bae ; Van Cutsem, Eric ; Ajani, Jaffer...
Current Medical Research and Opinion. 40 (2023) 1 - p. 69-75 , 2023

Link: https://doi.org/10.1080/..

10

Small cell lung cancer patients treated with immune checkpo..:

Korde, Rasika ; Veluswamy, Rajwanth ; Allaire, Jason C..
Current Medical Research and Opinion. 38 (2022) 8 - p. 1361-1368 , 2022

Link: https://doi.org/10.1080/..

11

Examining the Impact of Tislelizumab Added to Chemotherapy ..:

Lu, Shun ; Yu, Yan ; Barnes, Gisoo...
The Cancer Journal. 28 (2022) 2 - p. 96-104 , 2022

Link: https://doi.org/10.1097/..

12

Real‐World longitudinal practice patterns in the use of PD‐..:

Veluswamy, Rajwanth ; Hirsch, Fred R. ; Taioli, Emanuela...
Cancer Medicine. 11 (2022) 22 - p. 4265-4272 , 2022

Link: https://doi.org/10.1002/..

13

Efficacy, safety, and health-related quality of life from a..:

Zhou, Caicun ; Huang, Dingzhi ; Yu, Xinmin...
Lung Cancer. 165 (2022) - p. S32-S33 , 2022

Link: https://doi.org/10.1016/..

14

Use of PD-1 and PD-L1 inhibitors after first-line therapy i..:

Allaire, Jason C. ; Balk, Mark ; Azmi, Soraya...
Current Medical Research and Opinion. 37 (2021) 8 - p. 1403-1407 , 2021

Link: https://doi.org/10.1080/..

15

Psychometric validation of the EORTC QLQ-HCC18 in patients ..:

Serrano, Daniel ; Podger, Lauren ; Barnes, Gisoo..
Quality of Life Research. 31 (2021) 3 - p. 937-950 , 2021

Link: https://doi.org/10.1007/..